Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Journey Medical (DERM) Short-Term Debt repayments (2021 - 2023)

Historic Short-Term Debt repayments for Journey Medical (DERM) over the last 3 years, with Q2 2023 value amounting to $3.0 million.

  • Journey Medical's Short-Term Debt repayments changed N/A to $3.0 million in Q2 2023 from the same period last year, while for Dec 2023 it was $30.9 million, marking a year-over-year increase of 98058.66%. This contributed to the annual value of $30.9 million for FY2023, which is 98058.66% up from last year.
  • Per Journey Medical's latest filing, its Short-Term Debt repayments stood at $3.0 million for Q2 2023.
  • In the past 5 years, Journey Medical's Short-Term Debt repayments ranged from a high of $27.9 million in Q1 2023 and a low of $812000.0 during Q1 2022
  • For the 3-year period, Journey Medical's Short-Term Debt repayments averaged around $6.9 million, with its median value being $2.1 million (2022).
  • Per our database at Business Quant, Journey Medical's Short-Term Debt repayments skyrocketed by 13108.11% in 2022 and then skyrocketed by 334187.19% in 2023.
  • Quarter analysis of 3 years shows Journey Medical's Short-Term Debt repayments stood at $888000.0 in 2021, then skyrocketed by 131.08% to $2.1 million in 2022, then surged by 46.2% to $3.0 million in 2023.
  • Its Short-Term Debt repayments stands at $3.0 million for Q2 2023, versus $27.9 million for Q1 2023 and $2.1 million for Q4 2022.